Clinical Report: Impact of Antipsychotic Drug Administration in Individuals with Dementia
Overview
{'add': 'Include confidence interval for mortality risk.'}
Background
Dementia affects over 55 million individuals globally, with a significant prevalence of behavioral and psychological symptoms. Antipsychotic drugs are frequently prescribed to manage these symptoms, despite established safety concerns and recommendations for non-pharmacological interventions as first-line treatment. Understanding the risks associated with antipsychotic use in dementia is crucial for improving patient safety and care quality.
Data Highlights
{'add': 'Include additional relevant outcomes and their confidence intervals.'}
Key Findings
{'add': 'Mention limited evidence for other adverse outcomes.'}
